SPOT: Sequential Predictive Modeling of Clinical Trial Outcome with Meta-Learning

• URL: http://arxiv.org/abs/2304.05352v1
• Date: Fri, 7 Apr 2023 23:04:27 GMT
• Title: SPOT: Sequential Predictive Modeling of Clinical Trial Outcome with Meta-Learning
• Authors: Zifeng Wang and Cao Xiao and Jimeng Sun
• Abstract summary: Clinical trials are essential to drug development but time-consuming, costly, and prone to failure. We propose Sequential Predictive mOdeling of clinical Trial outcome (SPOT) that first identifies trial topics to cluster the multi-sourced trial data into relevant trial topics. With the consideration of each trial sequence as a task, it uses a meta-learning strategy to achieve a point where the model can rapidly adapt to new tasks with minimal updates.
• Score: 67.8195828626489
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Clinical trials are essential to drug development but time-consuming, costly, and prone to failure. Accurate trial outcome prediction based on historical trial data promises better trial investment decisions and more trial success. Existing trial outcome prediction models were not designed to model the relations among similar trials, capture the progression of features and designs of similar trials, or address the skewness of trial data which causes inferior performance for less common trials. To fill the gap and provide accurate trial outcome prediction, we propose Sequential Predictive mOdeling of clinical Trial outcome (SPOT) that first identifies trial topics to cluster the multi-sourced trial data into relevant trial topics. It then generates trial embeddings and organizes them by topic and time to create clinical trial sequences. With the consideration of each trial sequence as a task, it uses a meta-learning strategy to achieve a point where the model can rapidly adapt to new tasks with minimal updates. In particular, the topic discovery module enables a deeper understanding of the underlying structure of the data, while sequential learning captures the evolution of trial designs and outcomes. This results in predictions that are not only more accurate but also more interpretable, taking into account the temporal patterns and unique characteristics of each trial topic. We demonstrate that SPOT wins over the prior methods by a significant margin on trial outcome benchmark data: with a 21.5\% lift on phase I, an 8.9\% lift on phase II, and a 5.5\% lift on phase III trials in the metric of the area under precision-recall curve (PR-AUC).

Related papers

• Can artificial intelligence predict clinical trial outcomes? [5.326858857564308]
  This study evaluates the predictive capabilities of large language models (LLMs) in determining clinical trial outcomes. We compare the models' performance using metrics including balanced accuracy, specificity, recall, and Matthews Correlation Coefficient (MCC) Oncology trials, characterized by high complexity, remain challenging for all models.
  arXiv  Detail & Related papers  (2024-11-26T17:05:27Z)
• TrialSynth: Generation of Synthetic Sequential Clinical Trial Data [21.799655542003677]
  Variational Autoencoder (VAE) designed to address challenges of generating synthetic time-sequence clinical trial data. Our experiments demonstrate that Trial Synth surpasses the performance of other comparable methods.
  arXiv  Detail & Related papers  (2024-09-11T08:20:30Z)
• CTP-LLM: Clinical Trial Phase Transition Prediction Using Large Language Models [5.4315728770105185]
  We investigate Clinical Trial Outcome Prediction (CTOP) using trial design documents to predict phase transitions automatically. Our fine-tuned GPT-3.5-based model (CTP-LLM) predicts clinical trial phase transition by analyzing the trial's original protocol texts without requiring human-selected features.
  arXiv  Detail & Related papers  (2024-08-20T16:43:05Z)
• TrialBench: Multi-Modal Artificial Intelligence-Ready Clinical Trial Datasets [57.067409211231244]
  This paper presents meticulously curated AIready datasets covering multi-modal data (e.g., drug molecule, disease code, text, categorical/numerical features) and 8 crucial prediction challenges in clinical trial design. We provide basic validation methods for each task to ensure the datasets' usability and reliability. We anticipate that the availability of such open-access datasets will catalyze the development of advanced AI approaches for clinical trial design.
  arXiv  Detail & Related papers  (2024-06-30T09:13:10Z)
• Language Interaction Network for Clinical Trial Approval Estimation [37.60098683485169]
  We introduce the Language Interaction Network (LINT), a novel approach that predicts trial outcomes using only the free-text descriptions of the trials. We have rigorously tested LINT across three phases of clinical trials, where it achieved ROC-AUC scores of 0.770, 0.740, and 0.748.
  arXiv  Detail & Related papers  (2024-04-26T14:50:59Z)
• TrialDura: Hierarchical Attention Transformer for Interpretable Clinical Trial Duration Prediction [19.084936647082632]
  We propose TrialDura, a machine learning-based method that estimates the duration of clinical trials using multimodal data. We encode them into Bio-BERT embeddings specifically tuned for biomedical contexts to provide a deeper and more relevant semantic understanding. Our proposed model demonstrated superior performance with a mean absolute error (MAE) of 1.04 years and a root mean square error (RMSE) of 1.39 years compared to the other models.
  arXiv  Detail & Related papers  (2024-04-20T02:12:59Z)
• HINT: Hierarchical Interaction Network for Trial Outcome Prediction Leveraging Web Data [56.53715632642495]
  Clinical trials face uncertain outcomes due to issues with efficacy, safety, or problems with patient recruitment. In this paper, we propose Hierarchical INteraction Network (HINT) for more general, clinical trial outcome predictions.
  arXiv  Detail & Related papers  (2021-02-08T15:09:07Z)
• Bayesian prognostic covariate adjustment [59.75318183140857]
  Historical data about disease outcomes can be integrated into the analysis of clinical trials in many ways. We build on existing literature that uses prognostic scores from a predictive model to increase the efficiency of treatment effect estimates.
  arXiv  Detail & Related papers  (2020-12-24T05:19:03Z)
• Increasing the efficiency of randomized trial estimates via linear adjustment for a prognostic score [59.75318183140857]
  Estimating causal effects from randomized experiments is central to clinical research. Most methods for historical borrowing achieve reductions in variance by sacrificing strict type-I error rate control.
  arXiv  Detail & Related papers  (2020-12-17T21:10:10Z)
• Fine-Tuning Pretrained Language Models: Weight Initializations, Data Orders, and Early Stopping [62.78338049381917]
  Fine-tuning pretrained contextual word embedding models to supervised downstream tasks has become commonplace in natural language processing. We experiment with four datasets from the GLUE benchmark, fine-tuning BERT hundreds of times on each while varying only the random seeds. We find substantial performance increases compared to previously reported results, and we quantify how the performance of the best-found model varies as a function of the number of fine-tuning trials.
  arXiv  Detail & Related papers  (2020-02-15T02:40:10Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.